Cleared Traditional

K213197 - MyOnyx System

K213197 is the FDA 510(k) clearance for MyOnyx System by Thought Technology , Ltd.. It is a Class 2 Physical Medicine device (product code IPF) cleared through the Traditional 510(k) pathway after a 261-day FDA review.

K213197 · Thought Technology , Ltd. · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2022
Decision
261d
Days
Class 2
Risk

K213197 is an FDA 510(k) clearance for the MyOnyx System. Classified as Stimulator, Muscle, Powered (product code IPF), Class II - Special Controls.

Submitted by Thought Technology , Ltd. (Montreal, CA). The FDA issued a Cleared decision on June 17, 2022 after a review of 261 days - an extended review cycle.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5850 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Physical Medicine review framework, consistent with the majority of Class II 510(k) submissions.

View all Thought Technology , Ltd. devices

Submission Details

510(k) Number K213197 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 29, 2021
Decision Date June 17, 2022
Days to Decision 261 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
146d slower than avg
Panel avg: 115d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IPF Stimulator, Muscle, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 890.5850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Physical Medicine devices follow this clearance model.

Regulatory Peers - IPF Stimulator, Muscle, Powered

All 134
Devices cleared under the same product code (IPF) and FDA review panel - the closest regulatory comparables to K213197.
Flex-MI
K221958 · Emsi, Inc. · Oct 2022
Biological Feedback and Stimulation System
K222201 · Medlander Medical Technology, Inc. · Oct 2022
Shoulder PacemakerTM
K220994 · Ncs Lab Srl · Oct 2022
Motive Knee Wrap
K220738 · Cymedica Orthopedics, Inc. · May 2022
geko W-3
K220327 · Firstkind Limited · Mar 2022
Levator Elite (Model LE9011)
K213043 · Shenzhen Dongdixin Technology Co., Ltd. · Feb 2022